Search

everythinglearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Microbes might play a role in vitiligo.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Lower LDL-c levels predict higher COVID-19 mortality.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

No cure exists for alopecia areata, and treatments are personalized.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.